RxDoctor Payments Data

Ramon Sueiro, MD

Family Medicine · Clermont, FLNPI 1790854560

Payments from drug & device makers

$420in general payments, 2019–2025

Across 23 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$121
  • Lilly USA, LLC$102
  • Boehringer Ingelheim$40
  • Johnson & Johnson$39
  • AstraZeneca$34
  • Amgen$30
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$420 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$136,428
Medicare patients
205
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban87$106,067
OzempicSemaglutide28$54,171
JanuviaSitagliptin Phosphate28$42,647
RybelsusSemaglutide15$41,171
XareltoRivaroxaban45$39,547
JardianceEmpagliflozin21$33,277
MounjaroTirzepatide24$31,934
TrulicityDulaglutide20$29,188
Janumet XrSitagliptin Phos/Metformin Hcl14$23,116
JanumetSitagliptin Phos/Metformin Hcl15$23,037
FarxigaDapagliflozin Propanediol12$18,710
Tresiba Flextouch U-100Insulin Degludec11$13,346
Lantus SolostarInsulin Glargine,hum.Rec.Anlog61$8,920
Atorvastatin Calcium637$5,862
Gabapentin140$3,506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$121$106,06787 claims
Novo NordiskOzempic, Rybelsus$16$95,34343 claims
Lilly USA, LLCMounjaro, Trulicity$102$61,12244 claims
Johnson & JohnsonXarelto$39$39,54745 claims
Boehringer IngelheimJardiance$40$33,27721 claims
AstraZenecaFarxiga$34$18,71012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →